Oramed Pharmaceuticals (ORMP)

Add to Watchlists
Create an Alert
12.19 -0.35  -2.79% NASDAQ Apr 17, 4:59PM BATS Real time Currency in USD
View Full Chart
ORMP Price Chart
View All Performance Charts

ORMP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Oramed Pharmaceuticals is up 76.41% over the last year vs S&P 500 Total Return up 20.96%, Novavax up 60.16%, and Galena Biopharma down 23.08%.

Get Quote for

Portfolio Strategies Featuring ORMP

Did Oramed Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ORMP Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Israel
  • Headquarters State/Province: N/A
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: May 31, 2014
  • Est. Current Fiscal Year End: August 31, 2014
  • Last Fiscal Quarter End: May 31, 2013
  • Last Fiscal Year End: August 31, 2012
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Oramed Pharmaceuticals is a pharmaceutical company. It is engaged in the research and development of innovative pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ORMP 12.19 -0.35 -2.79% 119.17M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.